Head to Head Survey: Nanovibronix (FEED) & Its Peers

Nanovibronix (NASDAQ:FEED) is one of 27 public companies in the “Surgical, Medical, And Dental Instruments And Supplies” industry, but how does it weigh in compared to its peers? We will compare Nanovibronix to similar businesses based on the strength of its profitability, analyst recommendations, institutional ownership, earnings, dividends, valuation and risk.

Institutional & Insider Ownership

16.4% of Nanovibronix shares are held by institutional investors. Comparatively, 19.3% of shares of all “Surgical, Medical, And Dental Instruments And Supplies” companies are held by institutional investors. 1.4% of Nanovibronix shares are held by insiders. Comparatively, 19.5% of shares of all “Surgical, Medical, And Dental Instruments And Supplies” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of current ratings and target prices for Nanovibronix and its peers, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nanovibronix	1	0	0	0	1.00
Nanovibronix Competitors	80	82	167	7	2.30

As a group, “Surgical, Medical, And Dental Instruments And Supplies” companies have a potential upside of 53.86%. Given Nanovibronix’s peers stronger consensus rating and higher probable upside, analysts plainly believe Nanovibronix has less favorable growth aspects than its peers.

Valuation and Earnings

This table compares Nanovibronix and its peers gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Nanovibronix	$2.56 million	-$3.70 million	-0.05
Nanovibronix Competitors	$62.62 million	-$27.52 million	1.57

Nanovibronix’s peers have higher revenue, but lower earnings than Nanovibronix. Nanovibronix is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Nanovibronix and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nanovibronix	-275.12%	-24.78%	-19.24%
Nanovibronix Competitors	-500.48%	-116.39%	-48.91%

Volatility & Risk

Nanovibronix has a beta of 2.26, indicating that its share price is 126% more volatile than the S&P 500. Comparatively, Nanovibronix’s peers have a beta of 1.80, indicating that their average share price is 80% more volatile than the S&P 500.

Summary

Nanovibronix peers beat Nanovibronix on 8 of the 13 factors compared.

About Nanovibronix

NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low-intensity, surface acoustic wave technology. … NanoVibronix’ catheter-based products include the UroShield™ and NG-Shield™ devices that are both CE mark certified.